Table 3

Trends in exposure to adjunctive medications among children with Kawasaki disease, 2000–2014 (n=17 809)

Exposed (%)Change in odds of exposure (OR, 95% CI)
Multiple IVIG doses171.4 (1.2 to 1.6)
Steroids151.3 (1.1 to 1.5)
Immune modulator3.28.1 (5.6 to 11.7)
Any anticoagulation2.81.0 (0.7 to 1.5)
Anti-platelet1.41.6 (1.0 to 2.6)
Low molecular weight heparin1.31.6 (1.0 to 2.7)
Warfarin0.90.3 (0.1 to 0.5)